These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 2435664

  • 1. A highly leukemogenic radiation leukemia virus isolate is a thymotropic, immunosuppressive retrovirus with a unique RNA structure.
    Ben David Y, Kotler M, Yefenof E.
    Int J Cancer; 1987 Apr 15; 39(4):492-7. PubMed ID: 2435664
    [Abstract] [Full Text] [Related]

  • 2. Studies on emerging radiation leukemia virus variants in C57BL/Ka mice.
    Rassart E, Shang M, Boie Y, Jolicoeur P.
    J Virol; 1986 Apr 15; 58(1):96-106. PubMed ID: 3005663
    [Abstract] [Full Text] [Related]

  • 3. High- and low-leukemogenic variants of the radiation leukemia virus (RadLV): immunogenic, suppressive and genetic properties in relation to leukemogenic activity.
    Yefenof E, Ben David Y, Kotler M.
    Int J Cancer; 1984 Dec 15; 34(6):875-82. PubMed ID: 6439654
    [Abstract] [Full Text] [Related]

  • 4. In vitro infection of lymphoid cells by thymotropic radiation leukemia virus grown in vitro.
    Haas M, Hilgers J.
    Proc Natl Acad Sci U S A; 1975 Sep 15; 72(9):3546-50. PubMed ID: 171665
    [Abstract] [Full Text] [Related]

  • 5. In vitro generation of cytotoxic lymphocytes against radiation- and radiation leukemia virus-induced tumors. III. Suppression of anti-tumor immunity in vitro by lymphocytes of mice undergoing radiation leukemia virus-induced leukemogenesis.
    Yefenof E, Meidav A, Kedar E.
    J Exp Med; 1980 Dec 01; 152(6):1473-83. PubMed ID: 6256461
    [Abstract] [Full Text] [Related]

  • 6. Leukemogenic activity of thymotropic, ecotropic, and xenotropic radiation leukemia virus isolates.
    Haas M.
    J Virol; 1978 Mar 01; 25(3):705-9. PubMed ID: 205667
    [Abstract] [Full Text] [Related]

  • 7. New class of leukemogenic ecotropic recombinant murine leukemia virus isolated from radiation-induced thymomas of C57BL/6 mice.
    Rassart E, Sankar-Mistry P, Lemay G, DesGroseillers L, Jolicoeur P.
    J Virol; 1983 Feb 01; 45(2):565-75. PubMed ID: 6300420
    [Abstract] [Full Text] [Related]

  • 8. Measurement of binding specificity between T cell lymphomas and murine leukemia viruses.
    O'Neill HC, Weissman IL.
    J Immunol Methods; 1989 Aug 15; 122(1):79-90. PubMed ID: 2547874
    [Abstract] [Full Text] [Related]

  • 9. Immunity and suppression in radiation- and radiation leukemia virus (RadLV)-induced leukemogenesis.
    Yefenof E, Ben-David Y.
    Leuk Res; 1986 Aug 15; 10(7):797-801. PubMed ID: 2942733
    [Abstract] [Full Text] [Related]

  • 10. T-cell lymphoma induction by radiation leukemia virus in athymic nude mice.
    Ricciardi-Castagnoli P, Lieberman M, Finn O, Kaplan HS.
    J Exp Med; 1978 Nov 01; 148(5):1292-310. PubMed ID: 214507
    [Abstract] [Full Text] [Related]

  • 11. In vivo antigenic modification of tumor cells. III. Metastatic thymic lymphoma specifically infected by thymotropic retrovirus.
    Iglehart JD, Weinhold KJ, Huper G, Thiel K, Bolognesi DP.
    J Natl Cancer Inst; 1981 Jul 01; 67(1):123-30. PubMed ID: 6265678
    [Abstract] [Full Text] [Related]

  • 12. Determinants of thymotropism in Kaplan radiation leukemia virus and nucleotide sequence of its envelope region.
    Poliquin L, Bergeron D, Fortier JL, Paquette Y, Bergeron R, Rassart E.
    J Virol; 1992 Aug 01; 66(8):5141-6. PubMed ID: 1629969
    [Abstract] [Full Text] [Related]

  • 13. A role for elevated H-2 antigen expression in resistance to neoplasia caused by radiation-induced leukemia virus. Enhancement of effective tumor surveillance by killer lymphocytes.
    Meruelo D.
    J Exp Med; 1979 Apr 01; 149(4):898-909. PubMed ID: 219130
    [Abstract] [Full Text] [Related]

  • 14. Suppressor and reactive lymphocytes in radiation leukemia virus (RadLV)-induced leukemogenesis.
    Yefenof E, Ben-David Y.
    Cancer Immunol Immunother; 1983 Apr 01; 16(1):48-52. PubMed ID: 6227381
    [Abstract] [Full Text] [Related]

  • 15. High- and low-leukemogenic variants of the radiation leukemia virus (RadLV) differ in ability to induce tumor-specific immune suppression.
    Yefenof E, Zilcha D.
    Int J Cancer; 1982 Sep 15; 30(3):355-9. PubMed ID: 6215365
    [Abstract] [Full Text] [Related]

  • 16. Radiation leukemia in C57BL/6 mice. II. Lack of ecotropic virus expression in the majority of lymphomas.
    Ihle JN, Joseph DR, Pazmino NH.
    J Exp Med; 1976 Dec 01; 144(6):1406-23. PubMed ID: 63529
    [Abstract] [Full Text] [Related]

  • 17. Abrogation of radiation leukemia virus-induced lymphomagenesis by antisera to thymotropic but not to ecotropic or dual-tropic viruses.
    Haas M, Jongstra J.
    J Virol; 1980 Nov 01; 36(2):606-10. PubMed ID: 6253681
    [Abstract] [Full Text] [Related]

  • 18. Immunologic characteristics in relation to high and low leukemogenic activity of radiation leukemia virus variants. I. Cellular analysis of immunosuppression.
    Haran-Ghera N, Ben-Yaakov M, Peled A.
    J Immunol; 1977 Feb 01; 118(2):600-6. PubMed ID: 320261
    [Abstract] [Full Text] [Related]

  • 19. Radiation leukemia virus: a marker for the study of intrathymic T cell differentiation.
    Boniver J, Delvenne C, Janowski M, Courtoy R, Defresne MP.
    Thymus; 1989 Feb 01; 14(1-3):109-13. PubMed ID: 2560269
    [Abstract] [Full Text] [Related]

  • 20. Immunologic characteristics in relation to high and low leukemogenic activity of radiation leukemia virus variants. II. Analysis of the immune response.
    Haran-Ghera N, Rubio N.
    J Immunol; 1977 Feb 01; 118(2):607-11. PubMed ID: 839072
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.